Reopro

DRUG2 trials

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS), University Hospital Tuebingen

Conditions

Arterial Occlusive DiseasesCerebrovascular Accident

Phase 2

ReoPro and Retavase to Treat Acute Stroke

CompletedNCT00046293

National Institute of Neurological Disorders and Stroke (NINDS)Cerebrovascular Accident

Start: 2002-09-24End: 2007-07-20Target: 72Updated: 2017-07-02

Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease

University Hospital TuebingenArterial Occlusive Diseases

Start: 2002-01-31End: 2009-12-31Target: 420Updated: 2006-09-12